Logo
x

Search

Subscribe Now

dr. reddy

Dr. Reddy’s Ituxredi (Biosimilar, MabThera) Receives the CHMP’s Positive Opinion

Dr. Reddy’s Ituxredi (Biosimilar, MabThera) Receives the CHMP’s Positive Opinion

  • July 29, 2024
Dr. Reddy's Laboratories Expects the Launch of Versavo (biosimilar, bevacizumab) for the Treatment of Several Cancer Indications Across the UK

Dr. Reddy's Laboratories Expects the Launch of Versavo (biosimilar, bevacizumab) for the Treatment of Several Cancer Indications A...

  • March 19, 2024
Dr. Reddy’s Reports BLA Acceptance for DRL_RI, a Proposed Biosimilar Rituximab by the US FDA, EMA and MHRA

Dr. Reddy’s Reports BLA Acceptance for DRL_RI, a Proposed Biosimilar Rituximab by the US FDA, EMA and MHRA

  • July 13, 2023
Insights+ Key Biosimilars Events of June 2023

Insights+ Key Biosimilars Events of June 2023

  • July 6, 2023
Dr. Reddy Reports the Completion of the P-I Study of DRL_TC, a Proposed Biosimilar of Tocilizumab for Rheumatoid Arthritis

Dr. Reddy Reports the Completion of the P-I Study of DRL_TC, a Proposed Biosimilar of Tocilizumab for Rheumatoid Arthritis

  • June 5, 2023
Dr. Reddy’s Reports the Completion of Clinical Studies of Rituximab Biosimilar

Dr. Reddy’s Reports the Completion of Clinical Studies of Rituximab Biosimilar

  • January 20, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.